Innovation

UPMC, GV, Gates Frontier back $51M financing round for drug discovery company

Pittsburgh-based UPMC Enterprises, GV (formerly Google Ventures), and Gates Frontier participated in the $51 million expansion series B financing round for drug discovery company Cerevance.

Noah Schwartz

Monday, February 13th, 2023

The company will use the financing to support clinical trials focusing on Parkinson’s, amyotrophic lateral sclerosis and schizophrenia.

The expansion brings the company’s total series B financing round to $116 million, according to a Feb. 13 Cerevance news release provided to Becker’s.

Next Up in Innovation

How flu cases compare to past seasons

The flu season is off to a severe and early start, with outpatient visits for flu-like illness already reaching levels…

By: Mackenzie Bean
Yesterday
Flu visits hit decade-high in New York City: 3 updates

More than 9,850 patients visited New York City emergency departments with influenza-like symptoms during the week ending Dec. 20 —…

By: Elizabeth Gregerson
Yesterday
Patient-generated AI: 3 trends reshaping clinical visits

As generative AI tools increasingly shape how patients research symptoms, diagnoses and treatments, chief medical information officers say the challenge…

By: Ella Jeffries
Yesterday

Comments are closed.

How physician leaders are reshaping surgical ops: Lessons from WakeMed, Lee Health + more

Next Up in Innovation

How flu cases compare to past seasons

Flu visits hit decade-high in New York City: 3 updates

Patient-generated AI: 3 trends reshaping clinical visits

Join the 500,000+ healthcare executives who start their day with Becker’s